ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,101Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 939

$1.46M Total Retail Price of All Prescriptions

Rank: 10 out of 939

821 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 821 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

46% of this provider’s 821 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 19,302 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 2,187 1,202 S3 1 1
SIMVASTATIN 1,305 951 2 2
FUROSEMIDE 946 672 3 7
AMLODIPINE BESYLATE 925 702 4 6
POTASSIUM CHLORIDE 895 683 5 9
NEXIUM 796 485 6 18
METFORMIN HCL 697 446 7 8
GABAPENTIN 681 312 8 11
OMEPRAZOLE 678 470 9 5
METOPROLOL TARTRATE 628 480 10 10
LEVOTHYROXINE SODIUM 602 508 11 4
MELOXICAM 460 282 12 14
HYDROCHLOROTHIAZIDE 429 323 13 12
LISINOPRIL 402 322 14 3
BENAZEPRIL HCL 360 254 15 87
NIFEDIPINE ER 285 211 16 105
ATENOLOL 277 125 17 19
CYCLOBENZAPRINE HCL 275 142 R 18 36
CARISOPRODOL 274 13 R 19 51
CRESTOR 273 124 20 34
CLOPIDOGREL 268 167 21 28
CARVEDILOL 268 174 21 25
METOPROLOL SUCCINATE 263 257 23 21
ZOLPIDEM TARTRATE 261 125 24 20
TAMSULOSIN HCL 258 163 25 27
GLIMEPIRIDE 254 146 26 37
CITALOPRAM HBR 253 209 27 15
AZITHROMYCIN 245 157 28 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 240 176 29 23
AMLODIPINE BESYLATE-BENAZEPRIL 233 168 30 58
SUCRALFATE 227 145 31 96
PROAIR HFA 219 152 32 41
ATORVASTATIN CALCIUM 217 145 33 22
TERAZOSIN HCL 217 186 33 114
DONEPEZIL HCL 216 188 35 30
ISOSORBIDE MONONITRATE ER 207 168 36 53
IBUPROFEN 203 128 37 112
LOSARTAN-HYDROCHLOROTHIAZIDE 200 117 38 55
LOSARTAN POTASSIUM 200 157 38 29
ALLOPURINOL 198 117 40 31
QUINAPRIL HCL 197 148 41 133
ALENDRONATE SODIUM 195 176 42 40
RANITIDINE HCL 194 118 43 35
PLAVIX 193 133 44 48
ENALAPRIL MALEATE 188 151 45 65
TRAMADOL HCL 188 81 45 16
DIGOXIN 167 119 47 45
ZETIA 166 143 48 103
ADVAIR DISKUS 164 99 49 60
FLUOXETINE HCL 159 37 50 47
CIPROFLOXACIN HCL 156 89 51 54
NAPROXEN 152 97 52 72
BACLOFEN 151 75 53 157
DIOVAN HCT 147 79 54 74
LANTUS 145 95 55 59
METOCLOPRAMIDE HCL 143 71 56 119
SERTRALINE HCL 139 69 57 24
LOVASTATIN 137 47 58 46
CLONIDINE HCL 136 90 59 39
PRAVASTATIN SODIUM 128 90 60 13
LYRICA 128 13 60 63
NAMENDA 125 102 62 49
FLUTICASONE PROPIONATE 125 75 62 43
POLYETHYLENE GLYCOL 3350 121 84 64 57
SPIRIVA 119 59 65 73
AMITRIPTYLINE HCL 118 51 R 66 38
MEGESTROL ACETATE 113 85 R 67 136
DIOVAN 113 77 67 50
LIPITOR 112 73 69 127
BENAZEPRIL-HYDROCHLOROTHIAZIDE 112 68 69 235
TRIAMTERENE-HCTZ 105 96 71 33
WARFARIN SODIUM 104 75 72 17
KLOR-CON M20 97 63 73 90
PREDNISONE 96 65 74 42
METHOCARBAMOL 96 53 R 74 149
OXYCODONE HCL-ACETAMINOPHEN 95 43 S2 76 107
PEN NEEDLE 95 41 76 193
ESTRADIOL 94 61 R 78 79
AGGRENOX 93 75 79 153
GEMFIBROZIL 90 58 80 100
INSULIN SYRINGE 90 72 80 97
GLIPIZIDE XL 89 67 82 147
DETROL LA 89 53 82 155
CLOTRIMAZOLE-BETAMETHASONE 86 40 84 188
SINGULAIR 85 46 85 101
METHOTREXATE 84 27 86 240
LOVAZA 79 52 87 191
PAROXETINE HCL 78 27 88 70
CYMBALTA 76 45 89 44
ESCITALOPRAM OXALATE 75 68 90 61
BYSTOLIC 75 33 90 132
GLIPIZIDE 73 55 92 52
PANTOPRAZOLE SODIUM 73 31 92 66
CELEBREX 72 42 94 106
AMIODARONE HCL 71 56 95 160
PROPRANOLOL HCL 69 32 96 117
PHENYTOIN SODIUM EXTENDED 66 22 97 99
SPIRONOLACTONE 66 37 97 71
NITROSTAT 65 35 99 204
AMOXICILLIN 65 33 99 92
NOVOLOG MIX 70-30 65 65 99 276
HYDRALAZINE HCL 64 50 102 130
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 29 102 64
LEVEMIR FLEXPEN 64 26 102 190
MONTELUKAST SODIUM 63 26 105 172
VENTOLIN HFA 62 25 106 80
LEVOFLOXACIN 62 40 106 86
METHYLPREDNISOLONE 61 34 108 118
METOLAZONE 59 40 109 181
TRAMADOL HCL-ACETAMINOPHEN 59 45 109 181
PREMARIN 57 27 R 111 111
MORPHINE SULFATE 56 14 S2 112 186
MORPHINE SULFATE ER 56 0 S2 112 113
TRAZODONE HCL 55 18 114 26
FLUCONAZOLE 54 22 115 140
TIZANIDINE HCL 54 0 115 81
RAMIPRIL 53 36 117 91
LATANOPROST 52 50 118 233
MECLIZINE HCL 52 40 118 134
PROMETHAZINE HCL 52 27 R 118 68
CEPHALEXIN 51 36 121 77
ATENOLOL-CHLORTHALIDONE 50 15 122 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.